• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Obes (Lond) . Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19

tetano

Editor, Senior Moderator
Int J Obes (Lond)


. 2022 Jan 26.
doi: 10.1038/s41366-022-01071-w. Online ahead of print.
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19


Georgia Colleluori[SUP] #[/SUP][SUP] 1 [/SUP], Laura Graciotti[SUP] #[/SUP][SUP] 2 3 [/SUP], Mauro Pesaresi[SUP] 4 [/SUP], Angelica Di Vincenzo[SUP] 1 [/SUP], Jessica Perugini[SUP] 1 [/SUP], Eleonora Di Mercurio[SUP] 1 [/SUP], Sara Caucci[SUP] 3 [/SUP], Patrizia Bagnarelli[SUP] 3 [/SUP], Cristina M Zingaretti[SUP] 1 [/SUP], Enzo Nisoli[SUP] 5 [/SUP], Stefano Menzo[SUP] 3 [/SUP], Adriano Tagliabracci[SUP] 4 [/SUP], Annie Ladoux[SUP] 6 [/SUP], Christian Dani[SUP] 6 [/SUP], Antonio Giordano[SUP] 1 [/SUP], Saverio Cinti[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).
Methods: We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.
Results: Although there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects' lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.
Conclusions: This study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity.
 
Back
Top Bottom